Current Status of Catheter-based Mitral Valve Replacement

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Devices

Background:

• Severe mitral regurgitation (MR) poses a significant clinical challenge, particularly for patients at high surgical risk.
• Surgical mitral valve replacement is often contraindicated in these high-risk individuals, necessitating alternative therapeutic strategies.

Purpose of the Study:

• To review the current state-of-the-art in transcatheter mitral valve replacement (TMVR) technology.
• To evaluate the technical aspects and early clinical outcomes of various TMVR devices.
• To identify the prospects and challenges associated with TMVR.

Main Methods:

• Systematic review of current literature on TMVR devices and clinical studies.
• Analysis of technical characteristics, procedural success rates, and early complications.
• Evaluation of patient outcomes and identification of areas for future research.

Main Results:

• TMVR devices are under active clinical evaluation, with early experiences showing high procedural success rates.
• Key challenges include left ventricular outflow tract obstruction (LVOTO), access site complications, and thrombotic risk.
• Anticoagulatory therapy is often required, and long-term prosthesis durability and paravalvular leakage require further assessment.

Conclusions:

• TMVR demonstrates potential as a viable therapeutic option for high-risk patients with severe MR.
• Addressing challenges such as LVOTO, bleeding complications, and thrombotic risk is crucial for widespread adoption.
• Further research into smaller devices for transseptal implantation and optimal anticoagulation strategies is warranted.